Clinical Trials · NCT06909006

Semaglutide Treatment in Type 1 Diabetes

Name: Semaglutide Treatment in Type 1 Diabetes
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Not Yet RecruitingPhase 3Semaglutide

Phase: Phase 3
Recruitment status: Not Yet Recruiting
Sponsor: Nordsjaellands Hospital
Enrollment: 122
Start date: Oct 2025
Locations: 1 site, Denmark
Primary endpoint: Body weight

View Semaglutide compound reference